Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide. Mediterr J Hematol Infect Dis [Internet]. 2025 Apr. 30 [cited 2026 May 2];17(1):e2025038. Available from: https://www.mjhid.org/mjhid/article/view/5964